AU Stock MarketDetailed Quotes

HPC The Hydration Pharmaceuticals Co Ltd

Watchlist
  • 0.018
  • 0.0000.00%
20min DelayTrading Dec 10 11:10 AET
5.49MMarket Cap-0.31P/E (Static)

The Hydration Pharmaceuticals Co Ltd Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 30, 2023
(FY)Dec 30, 2022
(FY)Dec 30, 2021
Operating cash flow (direct method)
Cash income from operating activities
10.73%14.09M
72.43%12.72M
7.38M
Revenue from customers
8.84%14.09M
57.76%12.94M
--8.21M
Other cash income from operating activities
----
73.28%-220.73K
---826.1K
Cash paid
19.71%-21.72M
-46.08%-27.06M
-18.52M
Payments to suppliers for goods and services
19.71%-21.72M
-46.08%-27.06M
---18.52M
Direct interest paid
---774.69K
----
----
Operating cash flow
41.33%-8.41M
-28.64%-14.33M
---11.14M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities
-33.47%3.99M
-74.49%5.99M
23.49M
Net issuance payments of debt
----
-32.30%5.99M
--8.85M
Net common stock issuance
--3.99M
----
--16.6M
Net other financing activities
----
----
---1.96M
Cash from discontinued financing activities
Financing cash flow
-33.47%3.99M
-74.49%5.99M
--23.49M
Net cash flow
Beginning cash position
-56.14%6.88M
591.51%15.69M
--2.27M
Current changes in cash
46.98%-4.42M
-167.58%-8.34M
--12.35M
Effect of exchange rate changes
153.82%243.94K
-516.83%-453.25K
--108.74K
End cash Position
-60.80%2.7M
-53.19%6.89M
--14.72M
Free cash from
41.33%-8.41M
-28.64%-14.33M
---11.14M
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
(FY)Dec 30, 2023(FY)Dec 30, 2022(FY)Dec 30, 2021
Operating cash flow (direct method)
Cash income from operating activities 10.73%14.09M72.43%12.72M7.38M
Revenue from customers 8.84%14.09M57.76%12.94M--8.21M
Other cash income from operating activities ----73.28%-220.73K---826.1K
Cash paid 19.71%-21.72M-46.08%-27.06M-18.52M
Payments to suppliers for goods and services 19.71%-21.72M-46.08%-27.06M---18.52M
Direct interest paid ---774.69K--------
Operating cash flow 41.33%-8.41M-28.64%-14.33M---11.14M
Investing cash flow
Cash flow from continuing investing activities
Cash from discontinued investing activities
Financing cash flow
Cash flow from continuing financing activities -33.47%3.99M-74.49%5.99M23.49M
Net issuance payments of debt -----32.30%5.99M--8.85M
Net common stock issuance --3.99M------16.6M
Net other financing activities -----------1.96M
Cash from discontinued financing activities
Financing cash flow -33.47%3.99M-74.49%5.99M--23.49M
Net cash flow
Beginning cash position -56.14%6.88M591.51%15.69M--2.27M
Current changes in cash 46.98%-4.42M-167.58%-8.34M--12.35M
Effect of exchange rate changes 153.82%243.94K-516.83%-453.25K--108.74K
End cash Position -60.80%2.7M-53.19%6.89M--14.72M
Free cash from 41.33%-8.41M-28.64%-14.33M---11.14M
Accounting Standards US-GAAPUS-GAAPUS-GAAP
Heat List
AU
Overall
Symbol
Price
% Chg

No Data